Drug Information

Drug General Information
Drug ID
D02TVS
Former ID
DNC005038
Drug Name
Hexadecanoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527208]
Structure
Download
2D MOL

3D MOL
Formula
C16H32O2
Canonical SMILES
CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCCCCCCC<br />CC
InChI
1S/C35H69O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(36)41-31-33(32-42-44(38,39)40)43-35(37)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33H,3-32H2,1-2H3,(H2,38,39,40)/t33-/m1/s1
InChIKey
PORPENFLTBBHSG-MGBGTMOVSA-N
CAS Number
CAS 57-10-3
PubChem Compound ID
985
Target and Pathway
Target(s) Fatty acid-binding protein, adipocyte Target Info Inhibitor [527208]
Fatty acid-bindingprotein, epidermal Target Info Inhibitor [527208]
KEGG Pathway PPAR signaling pathwayhsa03320:PPAR signaling pathway
NetPath Pathway TCR Signaling PathwayNetPath_13:IL1 Signaling Pathway
Pathway Interaction Database AP-1 transcription factor network
Reactome Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
Transcriptional regulation of white adipocyte differentiationR-HSA-163560:Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
WikiPathways Lipid digestion, mobilization, and transport
Transcriptional Regulation of White Adipocyte Differentiation
References
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.